N. Nikitas

发表

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

K. Syrigos, T. Economopoulos, G. Fountzilas, 2012, BMC Cancer.

Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?

M. Dimopoulos, C. Papadimitriou, G. Bozas, 2010, Obstetrics and gynecology international.

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma

M. Dimopoulos, E. Kastritis, E. Terpos, 2013, Leukemia.

Endocrine dysregulation in aneurysmal subarachnoid haemorrhage

N. Nikitas, Thomas Roe, J. Welbourne, 2022, British journal of neurosurgery.

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Short progression‐free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent‐based therapy

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2011, European journal of haematology.

Yeast central nervous system infection in a critically ill patient: a case report

A. Armaganidis, G. Dimopoulos, A. Velegraki, 2014, Journal of Medical Case Reports.

Diarrhea and generalized weakness in a patient with metastatic melanoma and a lumbosacral mass, after initiation of therapy with a checkpoint inhibitor: A case report

N. Nikitas, Marija Cauchi, 2015 .

Multiple Organ Dysfunction Syndrome

N. Nikitas, Nicholas M. Gourd, N. M. Gourd, 2019, Journal of intensive care medicine.

Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2011, Clinical lymphoma, myeloma & leukemia.

Adipose Tissue Lactate Clearance but Not Blood Lactate Clearance Is Associated with Clinical Outcome in Sepsis or Septic Shock during the Post-Resuscitation Period

I. Dimopoulou, A. Kotanidou, I. Ilias, 2018, Metabolites.

Interrelationship between blood and tissue lactate in a general intensive care unit: a subcutaneous adipose tissue microdialysis study on 162 critically ill patients.

I. Dimopoulou, A. Armaganidis, I. Ilias, 2012, Journal of critical care.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

L-asparaginase fatal toxic encephalopathy during consolidation treatment in an adult with acute lymphoblastic leukemia

A. Armaganidis, G. Dimopoulos, N. Nikitas, 2013, The American journal of case reports.

Herpes simplex encephalitis following successful coiling of aneurysmal subarachnoid haemorrhage

N. Nikitas, A. MacCormick, W. Carr, 2020, British journal of neurosurgery.

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2012, Blood.

Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.

I. Dimopoulou, A. Armaganidis, I. Ilias, 2015, Journal of critical care.

A case of COVID-19 reinfection in the UK.

N. Nikitas, Jack West, S. Everden, 2020, Clinical medicine.

Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.

I. Adamakis, D. Pectasides, S. Murray, 2012, Pharmacogenomics.

and low-dose dexamethasone (RdC) in AL amyloidosis A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide

M. Gavriatopoulou, E. Terpos, M. Roussou, 2012 .

Interstitial cortisol obtained by microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol.

B. Keevil, N. Maniatis, S. Orfanos, 2013, Journal of critical care.

Circulating angiopoietin‐1 to angiopoietin‐2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

M. Dimopoulos, E. Kastritis, E. Katodritou, 2012, International journal of cancer.

Coronary flow reserve is associated with tissue ischemia and is an additive predictor of intensive care unit mortality to traditional risk scores in septic shock.

J. Lekakis, I. Dimopoulou, A. Armaganidis, 2014, International journal of cardiology.

Burkitt’s Lymphoma in Pregnancy with Bilateral Breast Involvement: Case Report with Review of the Literature

M. Dimopoulos, C. Papadimitriou, D. Christoulas, 2010, Oncology Research and Treatment.

Hydroxyurea use in patients with sickle cell disease in a Medicaid population

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2011, American journal of hematology/oncology.

K. Syrigos, T. Economopoulos, G. Fountzilas, 2012, BMC Cancer.

Microdialysis-assessed interstitium alterations during sepsis: relationship to stage, infection, and pathogen

U. Ungerstedt, S. Orfanos, I. Dimopoulou, 2011, Intensive Care Medicine.

Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels.

C. Roussos, S. Orfanos, I. Dimopoulou, 2012, Journal of critical care.

Increased expression of cyclin‐D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2012, American journal of hematology.

Kinetics of Adipose Tissue Microdialysis-Derived Metabolites in Critically Ill Septic Patients: Associations with Sepsis Severity and Clinical Outcome

U. Ungerstedt, N. Maniatis, S. Orfanos, 2011, Shock.

Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

N. Pavlidis, H. Gogas, R. Wirtz, 2012, Clinical breast cancer.

Endothelial protein C receptor polymorphisms and risk of severe sepsis in critically ill patients

N. Maniatis, E. Letsiou, S. Orfanos, 2013, Intensive Care Medicine.

Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens

M. Dimopoulos, E. Terpos, M. Roussou, 2011, Leukemia & lymphoma.

Enhanced analysis of somatosensory evoked potentials at 20–30 milliseconds can predict neurological outcome after cardiac arrest

Andrew Smith, N. Nikitas, C. Bigham, 2023, Clinical Neurophysiology.

Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis

U. Ungerstedt, N. Maniatis, S. Orfanos, 2012, Intensive Care Medicine.

Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: effects of shock and treatment.

I. Dimopoulou, A. Armaganidis, I. Ilias, 2014, Journal of critical care.

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

Glycolysis in Patients with Sepsis during Early ICU Hospitalization Shows Differences vis-Ã -vis Shock Resolution â An Adipose Tissue Microdialysis Study

I. Dimopoulou, I. Ilias, K. Laios, 2017 .

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Microdialysis-Assessed Adipose Tissue Metabolism, Circulating Cytokines and Outcome in Critical Illness

I. Dimopoulou, A. Kotanidou, I. Ilias, 2018, Metabolites.

Interstitial cortisol obtained by microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol.

B. Keevil, N. Maniatis, S. Orfanos, 2013, Journal of critical care.

Peer Review File Manuscript Title: Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19 Reviewer Comments & Author Rebuttals

Mohammed A. Eid, Daniel J. Wilson, Nathan D. Berkowitz, 2022 .

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Whole-genome sequencing reveals host factors underlying critical COVID-19

Eurie L. Hong, Mohammed A. Eid, Daniel J. Wilson, 2022, Nature.

Stratified analyses refine association between TLR7 rare variants and severe COVID-19

K. Rawlik, N. Sacchi, N. Love, 2024, HGG advances.

Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2011, Clinical lymphoma, myeloma & leukemia.